HMCell provides contract and consulting services to academic researchers, industry and investors, enhancing the capabilities and reputation of the ecosystem, thus accelerating the commercialization of cell and gene therapies, and regenerative medicine technologies. HMCell identifies, supports and de-risks promising new technologies and companies, enhancing deal flow. Our team combines extensive experience in company creation, academic excellence and seasoned professionals sourced from industry.